Support of Life Science Start-Up has Life-Changing Impact
Wednesday, January 25, 2017
Posted by: Kate Oesterle
Making medical procedures safer, more efficient through skeletal technologies
ymouth-based Tissue Regeneration Systems (TRS) formed in 2008 based on research and technologies licensed out of the Universities of Michigan and Wisconsin. TRS has two core technologies: 3-D printed bioresorbable scaffolds for bone repair and its Affinity™ coating, designed to help implants assimilate better into the body, reducing complications and accelerating healing.
“Founding the company during a tough economic time, we learned almost immediately that we needed to have a lean and low capital business model,” said Jim Fitzsimmons, who joined the company as CEO in 2010 following 30 years of experience in the medical device industry.
“We knew it would be challenging to build a fully commercial company, so we made strategic decisions to help us grow,” he said. “We are grateful for the support from MEDC and MLSIC (Michigan Life Science Innovation Center), and strengthened by our partnership with the JJIC (Johnson & Johnson Innovation Center).”
TRS is targeting five distinct markets, including craniomaxillofacial (CMF) surgery, orthopedic surgery, spine fusion surgery, dental implant surgery, and bone growth factor delivery. Their technologies have demonstrated an ability to truly cause a paradigm shift in the world of skeletal reconstruction.
Read full article.